Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,525 | 5 | 67.4% |
| Travel and Lodging | $1,209 | 5 | 12.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,020 | 1 | 10.5% |
| Food and Beverage | $864.59 | 23 | 8.9% |
| Education | $57.74 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $5,911 | 5 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $1,434 | 9 | $0 (2019) |
| Genentech USA, Inc. | $1,020 | 1 | $0 (2021) |
| Cheetah Medical, Inc. | $750.00 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $174.68 | 12 | $0 (2024) |
| La Jolla Pharmaceutical Company | $161.50 | 2 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $122.55 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $60.74 | 2 | $0 (2022) |
| Allergan Inc. | $24.85 | 2 | $0 (2017) |
| Insmed, Inc. | $16.24 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15.13 | 1 | GlaxoSmithKline, LLC. ($15.13) |
| 2023 | $3,299 | 4 | Baxter Healthcare ($3,273) |
| 2022 | $2,799 | 6 | Baxter Healthcare ($2,639) |
| 2021 | $1,252 | 7 | Genentech USA, Inc. ($1,020) |
| 2020 | $23.86 | 2 | GlaxoSmithKline, LLC. ($23.86) |
| 2019 | $1,478 | 12 | VERTEX PHARMACEUTICALS INCORPORATED ($1,434) |
| 2017 | $809.33 | 4 | Cheetah Medical, Inc. ($750.00) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: RESPIRATORY | ||||||
| 08/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2023 | Baxter Healthcare | STARLING SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $1,347.50 | General |
| Category: Fluid Systems | ||||||
| 02/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2023 | Baxter Healthcare | STARLING SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| Category: Fluid Systems | ||||||
| 11/19/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Respiratory | ||||||
| 11/03/2022 | Baxter Healthcare | STARLING SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $1,925.00 | General |
| Category: Fluid Systems | ||||||
| 10/18/2022 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $136.49 | General |
| Category: Renal | ||||||
| 05/05/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/20/2022 | Baxter Healthcare | Renal - Acute (Device) | Consulting Fee | Cash or cash equivalent | $577.50 | General |
| Category: Renal | ||||||
| 12/03/2021 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/18/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: IMMUNOLOGY | ||||||
| 05/25/2021 | Genentech USA, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,020.00 | General |
| 05/10/2021 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Education | In-kind items and services | $41.50 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/29/2021 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $16.24 | General |
| Category: Respiratory | ||||||
| 03/18/2021 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $198.41 | General |
| 10/28/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $155.79 | General |
| 10/28/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $84.60 | General |
| 10/28/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $60.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 500 | 645 | $184,574 | $48,330 |
| 2022 | 13 | 542 | 692 | $187,159 | $52,279 |
| 2021 | 8 | 341 | 509 | $179,085 | $58,353 |
| 2020 | 14 | 957 | 1,172 | $269,569 | $64,907 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 40 | 85 | $60,678 | $13,511 | 22.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 113 | $29,813 | $10,269 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 73 | 82 | $15,266 | $5,444 | 35.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 41 | $18,421 | $5,413 | 29.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 51 | $9,847 | $3,506 | 35.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 24 | 24 | $8,069 | $2,876 | 35.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 11 | 30 | $10,130 | $2,443 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 34 | $6,122 | $2,054 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 24 | $3,276 | $1,106 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $1,904 | $653.38 | 34.3% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 36 | 36 | $9,724 | $322.82 | 3.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 44 | 44 | $1,056 | $286.15 | 27.1% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 42 | 42 | $6,054 | $251.46 | 4.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 14 | 14 | $3,780 | $103.90 | 2.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 11 | 11 | $434.00 | $91.70 | 21.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 43 | 103 | $63,750 | $16,701 | 26.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 71 | 111 | $27,195 | $8,460 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 68 | 77 | $12,119 | $5,070 | 41.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 35 | 35 | $10,698 | $4,489 | 42.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 27 | 27 | $12,825 | $4,083 | 31.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 22 | 44 | $13,560 | $3,656 | 27.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 40 | $6,544 | $2,329 | 35.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 33 | $5,610 | $1,789 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $3,704 | $1,670 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 29 | $3,806 | $1,332 | 35.0% |
About Dr. Heath Latham, M.D
Dr. Heath Latham, M.D is a Critical Care Medicine healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2007. The National Provider Identifier (NPI) number assigned to this provider is 1639210123.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heath Latham, M.D has received a total of $9,676 in payments from pharmaceutical and medical device companies, with $15.13 received in 2024. These payments were reported across 36 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($6,525).
As a Medicare-enrolled provider, Latham has provided services to 2,340 Medicare beneficiaries, totaling 3,018 services with total Medicare billing of $223,869. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Kansas City, KS
- Active Since 02/09/2007
- Last Updated 09/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1639210123
Products in Payments
- STARLING SYSTEM (Device) $5,198
- Renal - Acute (Device) $713.99
- GIAPREZA (Drug) $161.50
- DUPIXENT (Biological) $122.55
- NUCALA (Biological) $62.86
- TRELEGY ELLIPTA (Drug) $55.41
- ANORO (Drug) $43.81
- BEVESPI AEROSPHERE (Drug) $34.48
- TEZSPIRE (Biological) $26.26
- Arikayce (Drug) $16.24
- AVYCAZ (Drug) $14.44
- ANORO ELLIPTA (Drug) $12.60
- DALVANCE (Drug) $10.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Kansas City
Dr. Mario Castro, Md, MD
Critical Care Medicine — Payments: $2.3M
Matthew Sharpe, M.d, M.D
Critical Care Medicine — Payments: $423,976
Harold Barkman, M.d, M.D
Critical Care Medicine — Payments: $97,847
Dr. Matthew Aboudara, M.d, M.D
Critical Care Medicine — Payments: $27,642
Dr. Robert Winfield, Md, MD
Critical Care Medicine — Payments: $12,986
Timothy Williamson, M.d, M.D
Critical Care Medicine — Payments: $8,096